<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PLGE-RA-1794R4</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1000631</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cell Biology/Membranes and Sorting</subject><subject>Genetics and Genomics/Disease Models</subject><subject>Neurological Disorders/Movement Disorders</subject><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>The Ataxia (<italic>ax</italic><sup>J</sup>) Mutation Causes Abnormal GABA<sub>A</sub> Receptor Turnover in Mice</article-title><alt-title alt-title-type="running-head">Altered GABA<sub>A</sub>R Turnover in <italic>ax</italic><sup>J</sup> Mice</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lappe-Siefke</surname><given-names>Corinna</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Loebrich</surname><given-names>Sven</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn1"><sup>&#x000a4;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hevers</surname><given-names>Wulf</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Waidmann</surname><given-names>Oliver B.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schweizer</surname><given-names>Michaela</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fehr</surname><given-names>Susanne</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fritschy</surname><given-names>Jean-Marc</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dikic</surname><given-names>Ivan</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Eilers</surname><given-names>Jens</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Scott M.</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kneussel</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Zentrum f&#x000fc;r Molekulare Neurobiologie Hamburg, Universit&#x000e4;t Hamburg, Hamburg, Germany</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Carl-Ludwig-Institut f&#x000fc;r Physiologie, Universit&#x000e4;t Leipzig, Leipzig, Germany</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Institut f&#x000fc;r Biochemie II, Universit&#x000e4;t Frankfurt, Frankfurt, Germany</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Klinik f&#x000fc;r Innere Medizin 1, Schwerpunkt Gastroenterologie und Hepatologie, Universit&#x000e4;t Frankfurt, Frankfurt, Germany</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Institute of Pharmacology und Toxicology, University of Zurich, Zurich, Switzerland</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Department of Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Frankel</surname><given-names>Wayne N.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">The Jackson Laboratory, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>matthias.kneussel@zmnh.uni-hamburg.de</email></corresp><fn id="fn1" fn-type="current-aff"><label>&#x000a4;</label><p>Current address: Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: CLS SL WH OBW ID JE SMW MK. Performed the experiments: CLS SL WH OBW MS SF JMF SMW. Analyzed the data: CLS SL WH OBW MS SF JE SMW MK. Contributed reagents/materials/analysis tools: JMF ID SMW. Wrote the paper: CLS MK.</p></fn></author-notes><pub-date pub-type="collection"><month>9</month><year>2009</year></pub-date><!-- Fake ppub added to accomodate plos workflow change from 03/2008 and 03/2009 --><pub-date pub-type="ppub"><month>9</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>4</day><month>9</month><year>2009</year></pub-date><volume>5</volume><issue>9</issue><elocation-id>e1000631</elocation-id><history><date date-type="received"><day>30</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>4</day><month>8</month><year>2009</year></date></history><permissions><copyright-statement>Lappe-Siefke et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><p>Ataxia represents a pathological coordination failure that often involves functional disturbances in cerebellar circuits. Purkinje cells (PCs) characterize the only output neurons of the cerebellar cortex and critically participate in regulating motor coordination. Although different genetic mutations are known that cause ataxia, little is known about the underlying cellular mechanisms. Here we show that a mutated <italic>ax</italic><sup>J</sup> gene locus, encoding the ubiquitin-specific protease 14 (Usp14), negatively influences synaptic receptor turnover. <italic>Ax</italic><sup>J</sup> mouse mutants, characterized by cerebellar ataxia, display both increased GABA<sub>A</sub> receptor (GABA<sub>A</sub>R) levels at PC surface membranes accompanied by enlarged IPSCs. Accordingly, we identify physical interaction of Usp14 and the GABA<sub>A</sub>R &#x003b1;1 subunit. Although other currently unknown changes might be involved, our data show that ubiquitin-dependent GABA<sub>A</sub>R turnover at cerebellar synapses contributes to <italic>ax</italic><sup>J</sup>-mediated behavioural impairment.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Cerebellar ataxia describes a combination of motor symptoms and uncoordinated movements that originates from various hereditary and non-hereditary diseases. Although functional disturbances of cerebellar inhibitory output signals are thought to cause ataxia, the underlying molecular mechanisms are barely understood and medical treatment therefore remains difficult. We analysed a behavioural abnormality up to the molecular level in a mouse mutant (<italic>ax</italic><sup>J</sup>) representing a model for ataxia. The <italic>ax</italic><sup>J</sup> mutation reduces the expression level of a ubiquitin protease (Usp14) leading to an abnormal turnover of neurotransmitter receptors. Despite other yet unknown changes in <italic>ax</italic><sup>J</sup> mutants, our data show that intracellular protein turnover contributes to a motor behavioural syndrome.</p></abstract><counts><page-count count="12"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>A number of heterogeneous hereditary and non-hereditary disorders lead to ataxia characterized by coordination failures <xref ref-type="bibr" rid="pgen.1000631-GrusserCornehls1">&#x0005b;1&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Klockgether1">&#x0005b;2&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Rosenberg1">&#x0005b;3&#x0005d;</xref>. The spontaneous <italic>ax</italic><sup>J</sup> mutation affects the locomotory system, causing an ataxic phenotype in mice <xref ref-type="bibr" rid="pgen.1000631-DAmato1">&#x0005b;4&#x0005d;</xref>. The mutated gene encodes the deubiquitinating enzyme (DUB) Usp14 <xref ref-type="bibr" rid="pgen.1000631-Wilson1">&#x0005b;5&#x0005d;</xref>, a member of the ubiquitin-specific protease family <xref ref-type="bibr" rid="pgen.1000631-Ehlers1">&#x0005b;6&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Yi1">&#x0005b;7&#x0005d;</xref>. Due to insertion of an intracisternal A-particle into intron 5, expression levels of full-length Usp14 in brains of <italic>ax</italic><sup>J</sup> mice are reduced to about 5&#x00025; <xref ref-type="bibr" rid="pgen.1000631-Wilson1">&#x0005b;5&#x0005d;</xref>.</p><p>Usp14 catalyzes the hydrolysis of isopeptide bonds in ubiquitin-protein conjugates <xref ref-type="bibr" rid="pgen.1000631-Chung1">&#x0005b;8&#x0005d;</xref>. Upon alternative splicing of exon 4, two isoforms of Usp14 are generated. The full-length isoform contains an addition of 33 amino acids, required for proteasome binding. Accordingly, binding of Usp14 to the proteasome is thought to be necessary for efficient hydrolyse activity of Usp14 <xref ref-type="bibr" rid="pgen.1000631-Crimmins1">&#x0005b;9&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Borodovsky1">&#x0005b;10&#x0005d;</xref>. <italic>Ax</italic><sup>J</sup> mice display an exclusive downregulation of the full-length isoform, thereby representing a specific knockdown of the proteasome binding form of Usp14. Although the proteasome is likely to be involved in the neurological dysfunctions <xref ref-type="bibr" rid="pgen.1000631-Crimmins1">&#x0005b;9&#x0005d;</xref>, Usp14 is unable to process polyubiquitin chains <xref ref-type="bibr" rid="pgen.1000631-Yin1">&#x0005b;11&#x0005d;</xref>. Since, its physiological substrate is thought to be mono- or oligoubiquitinated <xref ref-type="bibr" rid="pgen.1000631-Wilson1">&#x0005b;5&#x0005d;</xref>, rather than representing a polyubiquitinated protein destined for degradation at the proteasome, Usp14 may have several functions in ubiquitin-signaling pathways.</p><p>Ubiquitination is a key process in the regulation of synapse formation and function <xref ref-type="bibr" rid="pgen.1000631-Ehlers1">&#x0005b;6&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Yi1">&#x0005b;7&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-DiAntonio1">&#x0005b;12&#x0005d;</xref>. Following endocytosis, ubiquitinated receptors are sorted for lysosomal degradation, thereby preventing their recycling to the plasma membrane <xref ref-type="bibr" rid="pgen.1000631-Hicke1">&#x0005b;13&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Katzmann1">&#x0005b;14&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Raiborg1">&#x0005b;15&#x0005d;</xref>. For instance, the surface expression of glycine receptors (GlyRs) depends on ubiquitination, suggesting an important role for this process in the regulation of synaptic receptor levels <xref ref-type="bibr" rid="pgen.1000631-Buttner1">&#x0005b;16&#x0005d;</xref>. Moreover, ubiquitination of inhibitory GABA<sub>A</sub> receptors (GABA<sub>A</sub>Rs) has recently been shown to be activity-dependent and to regulate synaptic GABA<sub>A</sub>R accumulation <xref ref-type="bibr" rid="pgen.1000631-Saliba1">&#x0005b;17&#x0005d;</xref>.</p><p>GABA<sub>A</sub>Rs mediate the majority of fast synaptic inhibition in the mammalian brain. In the cerebellum, 75&#x00025; of all GABA<sub>A</sub>Rs contain the &#x003b1;1 subunit <xref ref-type="bibr" rid="pgen.1000631-Ogris1">&#x0005b;18&#x0005d;</xref>, whereas PCs exclusively express &#x003b1;1-containing GABA<sub>A</sub>Rs <xref ref-type="bibr" rid="pgen.1000631-Fritschy1">&#x0005b;19&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Wisden1">&#x0005b;20&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Wulff1">&#x0005b;21&#x0005d;</xref>.</p><p>PCs transform excitatory afferent signals to inhibitory efferents that target the neurons of the deep cerebellar nuclei (DCN) and vestibular nuclei (VN) <xref ref-type="bibr" rid="pgen.1000631-GrusserCornehls1">&#x0005b;1&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Voogd1">&#x0005b;22&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Sotelo1">&#x0005b;23&#x0005d;</xref>. Their inhibitory influence on DCN and VN neurons is a prerequisite for normal motor coordination, and even minor disturbances of cerebellar inhibition has been shown to cause uncoordinated movements and ataxia <xref ref-type="bibr" rid="pgen.1000631-GrusserCornehls1">&#x0005b;1&#x0005d;</xref>. Hence, mouse mutants characterized by Purkinje cell degeneration, such as <italic>pcd</italic> or leaner mice suffer from ataxia <xref ref-type="bibr" rid="pgen.1000631-Fletcher1">&#x0005b;24&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Herrup1">&#x0005b;25&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Lorenzon1">&#x0005b;26&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Mullen1">&#x0005b;27&#x0005d;</xref>.</p><p>Here, we show that the downregulation of Usp14 in <italic>ax</italic><sup>J</sup> mice is accompanied by a marked redistribution of intracellular &#x003b1;1-containing GABA<sub>A</sub>Rs to PC surface membranes, leading to enlarged IPSC amplitudes. We further demonstrate physical interaction of Usp14 and GABA<sub>A</sub>R &#x003b1;1, suggesting that Usp14 directly participates in the regulation of synaptic GABA<sub>A</sub>R turnover. Consistently, interference with GABA<sub>A</sub>R-Usp14 binding in a heterologous system mimics the <italic>in vivo</italic> observations. Our data demonstrate a new concept with the ubiquitin-proteasome system (UPS) representing a key player in synaptic neurotransmitter receptor regulation.</p></sec><sec id="s2"><title>Results/Discussion</title><sec id="s2a"><title>Reduced expression of Usp14 alters GABA<sub>A</sub>R signal intensities <italic>in vivo</italic></title><p>Mice carrying the <italic>ax</italic><sup>J</sup> mutation display reduced expression levels of the full-length Usp14 isoform in brain, whereas expression of the short Usp14 isoform remains unaltered (<xref ref-type="bibr" rid="pgen.1000631-Wilson1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="fig" rid="pgen-1000631-g001">Figure 1A</xref>). Phenotypically, <italic>ax</italic><sup>J</sup> mice demonstrate severe coordination failures and ataxia (<xref ref-type="fig" rid="pgen-1000631-g001">Figure 1B</xref>) <xref ref-type="bibr" rid="pgen.1000631-DAmato1">&#x0005b;4&#x0005d;</xref>, often linked to dysfunctions within cerebellar circuits <xref ref-type="bibr" rid="pgen.1000631-Duenas1">&#x0005b;28&#x0005d;</xref>. Although increased apoptotic cell death is reported in <italic>ax</italic><sup>J</sup>-derived cerebellar granule cell layers <xref ref-type="bibr" rid="pgen.1000631-Ohgoh1">&#x0005b;29&#x0005d;</xref>, application of nuclear staining revealed that the overall architecture of the cerebellum remains normal (<xref ref-type="fig" rid="pgen-1000631-g001">Figure 1C</xref>). To visualize PC bodies (arrows) and the molecular layer, representing PC dendrites, the PC marker protein Calbindin was immunolabeled. (<xref ref-type="fig" rid="pgen-1000631-g001">Figure 1D</xref>, upper panels, green). Parallel staining of GABA<sub>A</sub>Rs using antibodies specific for the &#x003b1;1-subunit (<xref ref-type="supplementary-material" rid="pgen.1000631.s001">Figure S1A-S1D</xref>) that represents the only &#x003b1;-type subunit in PCs, demonstrated strongly increased GABA<sub>A</sub>R cluster intensities in the molecular layer of <italic>ax</italic><sup>J</sup> compared to wt cerebellum (<xref ref-type="fig" rid="pgen-1000631-g001">Figure 1D</xref>, upper panels, red; lower panels, white). This phenomenon appeared to be mosaic and is in agreement with previous reports of variable expression levels of Usp14LF throughout different tissues <xref ref-type="bibr" rid="pgen.1000631-Wilson1">&#x0005b;5&#x0005d;</xref>. Notably, these effects were specific and due to decreased Usp14 levels, since neuron-specific transgenic expression of Usp14 on the background of <italic>ax</italic><sup>J</sup> mice <xref ref-type="bibr" rid="pgen.1000631-Crimmins1">&#x0005b;9&#x0005d;</xref> genetically reversed this effect, thereby leading to similar GABA<sub>A</sub>R &#x003b1;1 signal intensities as detected in wt PCs (<xref ref-type="fig" rid="pgen-1000631-g001">Figure 1D</xref>, <italic>ax</italic><sup>J</sup> x tg, right). Together, these data indicate that Usp14 regulates either the gene expression or the subcellular distribution of &#x003b1;1-containing GABA<sub>A</sub>Rs in PCs.</p><fig id="pgen-1000631-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000631.g001</object-id><label>Figure 1</label><caption><title><italic>Ax</italic><sup>J</sup> mice display altered <italic>in vivo</italic> surface membrane expression of &#x003b1;1-containing GABA<sub>A</sub>Rs.</title><p>(A) Domain structure of the full-length long form (LF) and short form (SF) of <italic>Usp14</italic>. The <italic>ax</italic><sup>J</sup> mutation leads to reduced expression of the Usp14LF <xref ref-type="bibr" rid="pgen.1000631-Wilson1">&#x0005b;5&#x0005d;</xref>. (B) <italic>Ax</italic><sup>J</sup> mice display ataxia and hind limb impairments. (C) The overall morphology of DAPI-stained <italic>ax</italic><sup>J</sup> cerebellar slices appears normal, as compared to slices derived from wt and <italic>ax</italic><sup>J</sup> mice that overexpress a neuron-specific <italic>Usp14</italic> transgene (<italic>ax</italic><sup>J</sup> x tg). Scale bar: 500 &#x000b5;m. (D) Upper panels: Coimmunohistochemistry on cerebellar slices using calbindin-specific (green) antibodies to label Purkinje cells (arrows) and GABA<sub>A</sub>R &#x003b1;1 (red) specific antibodies. For a better visualization of the GABA<sub>A</sub>R &#x003b1;1 signal, the lower panels exclusively depict the red channel in black and white mode. <italic>Ax</italic><sup>J</sup> mice display an increase of GABA<sub>A</sub>R &#x003b1;1 clusters especially in the molecular layer. Neuronal overexpression of a <italic>Usp14</italic> transgene on the <italic>ax</italic><sup>J</sup> background (<italic>ax</italic><sup>J</sup> x tg) rescues this effect <italic>in vivo</italic> (right). Scale bar: 100 &#x000b5;m. gl: granular layer; ml: molecular layer; pc: Purkinje cell layer.</p></caption><graphic xlink:href="pgen.1000631.g001"/></fig></sec><sec id="s2b"><title>Intracellular &#x003b1;1-containing GABA<sub>A</sub>Rs in PCs of <italic>ax</italic><sup>J</sup> mice are redistributed to surface membranes</title><p>To investigate the underlying mechanism of increased GABA<sub>A</sub>R clusters, PCs of wt and <italic>ax</italic><sup>J</sup> mice were analyzed at the subcellular level. Immunostaining of GABA<sub>A</sub>R &#x003b1;1 using either fluorophore- (<xref ref-type="fig" rid="pgen-1000631-g002">Figure 2A</xref>) or biotin-labeled (<xref ref-type="fig" rid="pgen-1000631-g002">Figure 2B</xref>) secondary antibodies revealed a marked increase in GABA<sub>A</sub>R &#x003b1;1 clusters at the surface of cell bodies and proximal dendrites (<xref ref-type="fig" rid="pgen-1000631-g002">Figure 2A and 2B</xref>, arrows). At the ultrastructural level, electron microscopy confirmed that large areas of the <italic>ax</italic><sup>J</sup> PC surface, including extrasynaptic sites, were covered by &#x003b1;1-containing GABA<sub>A</sub>Rs (<xref ref-type="fig" rid="pgen-1000631-g002">Figure 2C</xref>). Notably, the cytoplasm of PCs did not show increased signal intensities between the genotypes (<xref ref-type="fig" rid="pgen-1000631-g002">Figure 2A&#x02013;2C</xref>). In addition, western blot analysis of cerebellar protein extracts from wt and <italic>ax</italic><sup>J</sup> mice (<xref ref-type="fig" rid="pgen-1000631-g002">Figure 2D</xref>) as well as mRNA levels upon <italic>in situ</italic> hybridization (<xref ref-type="fig" rid="pgen-1000631-g002">Figure 2E</xref>) demonstrated equal signals of GABA<sub>A</sub>R &#x003b1;1 proteins and mRNAs in both genotypes, indicating that the total gene expression of GABA<sub>A</sub>R &#x003b1;1 is not increased. We therefore conclude that a major loss of Usp14 expression leads to a surface redistribution of intracellular &#x003b1;1-containing GABA<sub>A</sub>Rs rather than to a significant increase in GABA<sub>A</sub>R &#x003b1;1 expression levels.</p><fig id="pgen-1000631-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000631.g002</object-id><label>Figure 2</label><caption><title>&#x003b1;1-containing GABA<sub>A</sub>Rs are redistributed in PCs of <italic>ax</italic><sup>J</sup> mice.</title><p>GABA<sub>A</sub>R &#x003b1;1 staining of PCs in slices of wt or <italic>ax</italic><sup>J</sup> mice using Cy3- (A) or biotin- (B) labeled secondary antibodies. Scale bars: 20 &#x000b5;m. (C) EM analysis of GABA<sub>A</sub>R &#x003b1;1 using biotin-coupled secondary antibodies. Scale bars: 500 nm. (D) Western blot analysis of protein extracts from wt or <italic>ax</italic><sup>J</sup> cerebella reveals that the effects seen in (A&#x02013;C) represent a receptor redistribution rather than a change in total gene expression. Actin serves as a loading control. (E) <italic>In situ</italic> hybridisation using GABA<sub>A</sub>R &#x003b1;1 oligonucleotides revealed comparable mRNA levels in PC somata (arrows) as well as in dendrites of wt and <italic>ax</italic><sup>J</sup> mice shown in dark (upper panels, white dots) and bright (lower panels, blue dots) field images. Nuclei were visualized by H&#x000e4;malaun staining. Note that GABA<sub>A</sub>R &#x003b1;1 mRNA signals were absent upon use of sense control oligonucleotides (right panels). Scale bar, upper panel: 100 &#x000b5;m. Scale bar, lower panel: 50 &#x000b5;m. gl: granular layer; ml: molecular layer; pc: Purkinje cell layer.</p></caption><graphic xlink:href="pgen.1000631.g002"/></fig></sec><sec id="s2c"><title>Loss of Usp14 causes increased IPSC amplitudes in PCs</title><p>Consistent with the immunohistochemical data, analysis of IPSCs (n&#x0200a;&#x0003d;&#x0200a;10,000 events) indeed revealed that 67&#x00025; of <italic>ax</italic><sup>J</sup> PCs displayed a significant increase in GABAergic current amplitudes (<xref ref-type="fig" rid="pgen-1000631-g003">Figure 3A&#x02013;3D</xref>, and <xref ref-type="supplementary-material" rid="pgen.1000631.s002">Figure S2A</xref> and <xref ref-type="supplementary-material" rid="pgen.1000631.s002">Figure S2B</xref>). In parallel and as expected for a postsynaptic receptor phenomenon, the kinetic parameters, such as rise-time (10&#x02013;90&#x00025;) and decay-time (&#x003c4;) remained unaltered under these conditions, indicating that both genotypes display no major changes in neurotransmitter uptake or release mechanisms (<xref ref-type="supplementary-material" rid="pgen.1000631.s002">Figure S2C</xref>). However, the maximal amplitudes in <italic>ax</italic><sup>J</sup> animals (&#x0003e;150 pA) displayed significantly (p&#x0200a;&#x0003d;&#x0200a;0.005) higher decay time constants (&#x003c4;&#x0200a;&#x0003d;&#x0200a;12.1&#x000b1;3.1 ms), as compared to the decay time constants (&#x003c4;&#x0200a;&#x0003d;&#x0200a;10.3&#x000b1;2.9 ms) of maximal IPSC amplitudes in wt animals (80&#x02013;150 pA; <xref ref-type="supplementary-material" rid="pgen.1000631.s002">Figure S2C</xref>). Such differences are consistent with increased perisynaptic receptor numbers and support the immunochemical and EM observations. We therefore conclude that increased GABA<sub>A</sub>R levels at PC plasma membranes induce increased cerebellar inhibition, that leads to reduced inhibitory output levels of PCs. Notably, also PC degeneration (<italic>pcd</italic>) mutant mice display a severe decrease of PC inhibitory output and develop ataxia <xref ref-type="bibr" rid="pgen.1000631-GrusserCornehls1">&#x0005b;1&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Mullen1">&#x0005b;27&#x0005d;</xref>. In addition, GAT1 deficient mice, represented through prolonged GABA actions, due to disturbed GABA reuptake, suffer from ataxia <xref ref-type="bibr" rid="pgen.1000631-Chiu1">&#x0005b;30&#x0005d;</xref>. Hence, altered inhibitory input to PCs leads to similar behavioral consequences compared to the loss of cerebellar inhibitory output upon Purkinje cell degeneration. However, if the observations in the present study contributed to the ataxia phenotype of <italic>ax</italic><sup>J</sup> mice, one should identify a molecular link between GABA<sub>A</sub>R turnover and Usp14-mediated pathways.</p><fig id="pgen-1000631-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000631.g003</object-id><label>Figure 3</label><caption><title>IPSC amplitudes of <italic>ax</italic><sup>J</sup> PCs are reduced.</title><p>(A,B) Traces of spontaneous IPSCs recorded from PCs of (A) wt or (B) <italic>ax</italic><sup>J</sup> mice. Note that amplitudes in the <italic>ax</italic><sup>J</sup> mutant are larger than in the wt. (C) For the given examples, IPSC amplitude distributions of wt and <italic>ax</italic><sup>J</sup> PCs are shown. (D) The median value of IPSC amplitudes is 29&#x000b1;8 pA (n&#x0200a;&#x0003d;&#x0200a;6) in wt, compared to 85&#x000b1;51 pA in <italic>ax</italic><sup>J</sup> mice (n&#x0200a;&#x0003d;&#x0200a;6).</p></caption><graphic xlink:href="pgen.1000631.g003"/></fig></sec><sec id="s2d"><title>Usp14 and GABA<sub>A</sub>R &#x003b1;1 represent direct binding partners <italic>in vitro</italic></title><p>To determine, whether Usp14 and GABA<sub>A</sub>R &#x003b1;1 might physically interact, we applied the lexA-based MATCHMAKER yeast two-hybrid system using Usp14LF (prey) and the large intracellular loop of GABA<sub>A</sub>R &#x003b1;1 (aa 334&#x02013;420, bait). These experiments indeed revealed that Usp14 represents a direct GABA<sub>A</sub>R &#x003b1;1 binding partner (<xref ref-type="fig" rid="pgen-1000631-g004">Figure 4A</xref>). Fine mapping, using systematic GABA<sub>A</sub>R &#x003b1;1 deletion mutants, identified the Usp14 binding region within the first 13 amino acids of the &#x003b1;1 loop sequence (aa 334&#x02013;346) (<xref ref-type="fig" rid="pgen-1000631-g004">Figure 4A</xref>). Vice versa, the GABA<sub>A</sub>R &#x003b1;1 binding site within the Usp14 protein was localized at its C-terminal domain (<xref ref-type="fig" rid="pgen-1000631-g004">Figure 4B</xref>). In order to biochemically verify this interaction, we then applied a pull-down experiment using the GST-tagged GABA<sub>A</sub>R &#x003b1;1 loop (aa 334&#x02013;420). Endogenous Usp14 protein derived from mouse brain lysates specifically bound to the immobilized GST-tagged GABA<sub>A</sub>R &#x003b1;1 loop, but not to GST alone (<xref ref-type="fig" rid="pgen-1000631-g004">Figure 4C</xref>), indicating <italic>in vitro</italic> binding of the protease and the receptor polypeptide. Differential centrifugation of brain extracts revealed that both endogenous proteins cofractionate at P2 plasma-membrane (10,000&#x000d7;g), P3 vesicular (100,000&#x000d7;g), and P4 protein complex (400,000&#x000d7;g) fractions. However, while GABA<sub>A</sub>Rs are enriched at the plasma membrane (P2), Usp14 binds to the proteasome and is consequently enriched in fraction P4 (<xref ref-type="fig" rid="pgen-1000631-g004">Figure 4D</xref>). This marginal overlap is consistent with a transient enzyme-substrate complex, however turned out not to be sufficient to obtain coimmunoprecipitation under standard conditions. Nevertheless, a GFP-tagged Usp14 mutant (GFP-Usp14(H434A-D450A)), harboring two point mutations within its functional catalytic domain <xref ref-type="bibr" rid="pgen.1000631-Hu1">&#x0005b;31&#x0005d;</xref>, stabilized the complex, and enabled coprecipitation of both full-length binding partners derived from HEK293 cells (<xref ref-type="fig" rid="pgen-1000631-g004">Figure 4E</xref>). Together, these data demonstrate physical interaction of GABA<sub>A</sub>R &#x003b1;1 and the ubiquitin-specific protease Usp14, and suggest that the observed GABA<sub>A</sub>R redistribution in ataxia mice (<xref ref-type="fig" rid="pgen-1000631-g001">Figures 1</xref> and <xref ref-type="fig" rid="pgen-1000631-g002">2</xref>) is directly caused by the loss of Usp14, thereby indicating that GABA<sub>A</sub>R turnover is ubiquitin-dependent.</p><fig id="pgen-1000631-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000631.g004</object-id><label>Figure 4</label><caption><title>Usp14 and GABA<sub>A</sub>R &#x003b1;1 interact directly.</title><p>(A) Domain structure of the GABA<sub>A</sub>R &#x003b1;1 subunit protein and mapping of the Usp14 binding site within its intracellular TM3-TM4 loop sequence, using the yeast two hybrid system. Peptide 334&#x02013;346, derived from GABA<sub>A</sub>R &#x003b1;1, was fused to mRFP for the use as a competitive peptide (compare with <xref ref-type="fig" rid="pgen-1000631-g006">Figure 6</xref>). (B) Domain structure of the Usp14 protein. GABA<sub>A</sub>R &#x003b1;1 binds to the Usp14 C-terminus. (C) Pulldown of endogenous Usp14 from brain extracts using a GST-tagged GABA<sub>A</sub>R &#x003b1;1 loop sequence. (D) GABA<sub>A</sub>R &#x003b1;1 and Usp14 cofractionate, but are enriched at non-overlapping peaks. (E) Coimmunoprecipitation of GABA<sub>A</sub>R &#x003b1;1 and a GFP-tagged Usp14 active site mutant (GFP-Usp14-H434A-D450A) upon expression in HEK293 cells.</p></caption><graphic xlink:href="pgen.1000631.g004"/></fig></sec><sec id="s2e"><title>Usp14 and GABA<sub>A</sub>R &#x003b1;1 colocalize <italic>in vitro</italic> and <italic>in vivo</italic></title><p>We next asked whether both proteins colocalize at the subcellular level. While GABA<sub>A</sub>R &#x003b1;1 subunits have been extensively characterized in both tissues and cells <xref ref-type="bibr" rid="pgen.1000631-Viltono1">&#x0005b;32&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Nusser1">&#x0005b;33&#x0005d;</xref>, immunohistochemical analysis of Usp14 displayed a wide distribution in all layers of the cerebellum (<xref ref-type="fig" rid="pgen-1000631-g005">Figure 5A</xref>) and was detected at synaptic vesicle protein 2 (SV2)-positive synaptic sites in both cultured hippocampal and cerebellar neurons (<xref ref-type="fig" rid="pgen-1000631-g005">Figure 5B</xref>, and <xref ref-type="supplementary-material" rid="pgen.1000631.s001">Figure S1E</xref>, turquoise). For analysis at ultrastructural resolutions, we performed immunoelectron microscopy using biotin- (<xref ref-type="fig" rid="pgen-1000631-g005">Figure 5C</xref>, upper panel) or gold-labeled (<xref ref-type="fig" rid="pgen-1000631-g005">Figure 5C</xref>, middle and lower panels) secondary antibodies. In this assays Usp14 was detected in close proximity to and directly at postsynaptic sites (<xref ref-type="fig" rid="pgen-1000631-g005">Figure 5C</xref>, upper panel, arrows), at both the pre- and post-synapse, as well as directly at synaptic plasma membranes (<xref ref-type="fig" rid="pgen-1000631-g005">Figure 5C</xref>, middle and lower panels, arrowheads).</p><fig id="pgen-1000631-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000631.g005</object-id><label>Figure 5</label><caption><title>Usp14 and GABA<sub>A</sub>R &#x003b1;1 colocalize in cultured hippocampal neurons and cerebellar tissue slices.</title><p>(A) Immunohistochemistry on brain slices using Usp14-specific antibodies (PB&#x0002b;2, left) or without primary antibody (control, right). Further specificity controls are described by Crimmins et al. <xref ref-type="bibr" rid="pgen.1000631-Crimmins1">&#x0005b;9&#x0005d;</xref>. Scale bar 350 &#x000b5;m. (B) Coimmunostaining of cultured hippocampal neurons using Usp14- (PB&#x0002b;2, green) and SV2- (blue) specific antibodies. Turquoise puncta indicate partial colocalization of Usp14 and SV2 as a synaptic marker protein. Scale bars: 5 &#x000b5;m. (C) Electron microscopy analysis of DAB- (upper panel) or gold-labeled (middle and lower panel) Usp14 protein in Purkinje cells of mouse cerebellar slices using Usp14-specific antibodies (PB&#x0002b;2). Scale bars: 200 nm. (D) Coimmunocytochemistry of Usp14 <xref ref-type="bibr" rid="pgen.1000631-Borodovsky1">&#x0005b;10&#x0005d;</xref> (green) and GABA<sub>A</sub>R &#x003b1;1 (red) reveals partial colocalization in neurites of cultured hippocampal neurons (yellow puncta, arrows). Scale bar: 5 &#x000b5;m. (E) Electron microscopy upon single-immunogold-labeling using antibodies specific for GABA<sub>A</sub>R &#x003b1;1 (left) or double-immunogold-labeling of GABA<sub>A</sub>R &#x003b1;1 with either synaptophysin- (middle) or Usp14 (PB&#x0002b;2, right). GABA<sub>A</sub>R &#x003b1;1 signals are found in close proximity to Usp14 signals at tubular submembrane organelles (b; synaptic bouton) of mouse Purkinje cells (PCs). Scale bars, left and middle: 200 nm. Scale bar, right: 100 nm.</p></caption><graphic xlink:href="pgen.1000631.g005"/></fig><p>In addition and in consistence with the <italic>in vitro</italic> binding data, coimmunostaining with antibodies specific for Usp14 and the GABA<sub>A</sub>R &#x003b1;1 subunit revealed partial colocalization in both cultured hippocampal and cerebellar neurons (<xref ref-type="fig" rid="pgen-1000631-g005">Figure 5D</xref>, and <xref ref-type="supplementary-material" rid="pgen.1000631.s001">Figure S1F</xref>, yellow, white arrows). At ultrastructural levels, this could be confirmed using gold-labeled secondary antibodies of different particle sizes. In accordance to the literature <xref ref-type="bibr" rid="pgen.1000631-Nusser1">&#x0005b;33&#x0005d;</xref>, GABA<sub>A</sub>R &#x003b1;1 (black arrows) was localized opposed to unlabeled (<xref ref-type="fig" rid="pgen-1000631-g005">Figure 5E</xref>, left, arrows) or synaptophysin-positive presynaptic boutons (<xref ref-type="fig" rid="pgen-1000631-g005">Figure 5E</xref>, middle, arrows), while colabeling of Usp14 and GABA<sub>A</sub>R &#x003b1;1 was rather detected at submembrane tubular organelles (<xref ref-type="fig" rid="pgen-1000631-g005">Figure 5E</xref>, right, white arrow), described in both dendritic shafts and spines <xref ref-type="bibr" rid="pgen.1000631-Cooney1">&#x0005b;34&#x0005d;</xref>. In addition to the smooth endoplasmic reticulum (SER), tubular compartments are generated through merge of internalized vesicles and multivesicular body (MVB)-tubule complexes and serve as intracellular stores of material destined for recycling or degradation <xref ref-type="bibr" rid="pgen.1000631-Cooney1">&#x0005b;34&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Mukherjee1">&#x0005b;35&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Prekeris1">&#x0005b;36&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Prekeris2">&#x0005b;37&#x0005d;</xref>. Given the fact that organelles that mediate neurotransmitter receptor sorting are localized subsynaptically <xref ref-type="bibr" rid="pgen.1000631-Cooney1">&#x0005b;34&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Park1">&#x0005b;38&#x0005d;</xref> with ubiquitin serving as a signal for internalization <xref ref-type="bibr" rid="pgen.1000631-Mukhopadhyay1">&#x0005b;39&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Terrell1">&#x0005b;40&#x0005d;</xref>, both the observed in <italic>vitro</italic> binding (<xref ref-type="fig" rid="pgen-1000631-g004">Figure 4</xref>) and colocalization data (<xref ref-type="fig" rid="pgen-1000631-g005">Figure 5</xref>) suggest that Usp14 represents a direct regulator of GABA<sub>A</sub>R turnover.</p></sec><sec id="s2f"><title>GABA<sub>A</sub>Rs are ubiquitinated</title><p>To investigate whether GABA<sub>A</sub>R &#x003b1;1 might be a putative substrate for Usp14, we examined whether this subunit could be ubiquitinated in cells. Thus, HEK293T cells were transfected with GFP-tagged GABA<sub>A</sub>R &#x003b1;1, GABA<sub>A</sub>R &#x003b2;3, HA-tagged ubiquitin and either Usp14 wildtype (wt) or a catalytic mutant of Usp14, respectively (<xref ref-type="supplementary-material" rid="pgen.1000631.s004">Figure S4</xref>). Extracts of untransfected HEK293T cells served as controls. Upon immunoprecipitation, using anti-GFP antibodies, GABA<sub>A</sub>R &#x003b1;1-GFP was precipitated from extracts containing GABA<sub>A</sub>R &#x003b1;1-GFP (<xref ref-type="supplementary-material" rid="pgen.1000631.s004">Figure S4A</xref>, lower panel). Upon the use of HA-antibodies ubiquitinated forms of GABA<sub>A</sub>R &#x003b1;1 could be detected in extracts from transfected but not untransfected HEK293T cells (<xref ref-type="supplementary-material" rid="pgen.1000631.s004">Figure S4A</xref>, upper panel). The detection of ubiquitinated GABA<sub>A</sub>R &#x003b1;1 is in line with a recent publication that reported ubiquitinated GABA<sub>A</sub>R &#x003b2; subunits <xref ref-type="bibr" rid="pgen.1000631-Saliba1">&#x0005b;17&#x0005d;</xref>, suggesting that GABA<sub>A</sub>Rs in general are subject to ubiquitin conjugation. In particular the abundance of ubiquitinated GABA<sub>A</sub>R &#x003b1;1 forms between 75 and 100 kDa (<xref ref-type="supplementary-material" rid="pgen.1000631.s004">Figure S4A</xref>, upper panel, asterisk) is slightly increased in the presence of the Usp14 catalytic mutant, represented by a more intensive blurred signal (see magnified image in <xref ref-type="supplementary-material" rid="pgen.1000631.s004">Figure S4B</xref>). This observation suggests a stabilization of mono-/oligoubiquitinated GABA<sub>A</sub>R &#x003b1;1 polypeptides upon binding of a functionally inactive form of Usp14. Thus, Usp14 might represent a critical DUB to GABA<sub>A</sub>R &#x003b1;1. A balanced control of GABA<sub>A</sub>R ubiquitination and deubiquitination might therefore be an important determinant in regulating GABA<sub>A</sub>R surface expression in neurons.</p></sec><sec id="s2g"><title>Interference with GABA<sub>A</sub>R &#x003b1;1-Usp14 binding <italic>in vitro</italic> mimics <italic>in vivo</italic> observations from <italic>ax</italic><sup>J</sup> mice</title><p>If the above interpretations were true, a minimal heterologous system should verify that Usp14 directly affects GABA<sub>A</sub>R turnover. In addition to the loss of Usp14 in mice, we aimed to proof, whether heterologous overexpression of an isolated Usp14 binding site (compare with <xref ref-type="fig" rid="pgen-1000631-g004">Figure 4A</xref>) of GABA<sub>A</sub>R &#x003b1;1 would mimic the receptor surface distribution phenotype upon competitive interference with GABA<sub>A</sub>R &#x003b1;1&#x02013;Usp14 binding. Thus, HEK293 cells were transfected with constructs encoding GABA<sub>A</sub>R &#x003b1;1-GFP, GABA<sub>A</sub>R &#x003b2;3 and the monomeric red fluorescent protein (mRFP)-tagged Usp14 binding site of GABA<sub>A</sub>R &#x003b1;1 (mRFP-GABA<sub>A</sub>R &#x003b1;1(334&#x02013;346)) or with mRFP, respectively. Biotinylation of surface proteins, followed by immunoprecipitation, indeed revealed a 2.5-fold increase of GABA<sub>A</sub>R &#x003b1;1-GFP surface membrane levels in the presence of the competing peptide (<xref ref-type="fig" rid="pgen-1000631-g006">Figure 6A and 6B</xref>), thereby leading to the same functional consequence, as observed in <italic>ax</italic><sup>J</sup> mice. To verify both the expression and catalytical activity of Usp14 in HEK293 cells, we performed western blot analysis of protein extracts from kidney and cultured HEK293 cells, using a HA-tagged ubiquitin vinyl methyl ester (HAub-VME), active site probe <xref ref-type="bibr" rid="pgen.1000631-Borodovsky2">&#x0005b;41&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Walters1">&#x0005b;42&#x0005d;</xref>. Western blot analysis using HA-specific antibodies confirmed that HEK293 cells express catalytically active Usp14 (<xref ref-type="supplementary-material" rid="pgen.1000631.s003">Figure S3A</xref>). Hence, we conclude that the disruption of GABA<sub>A</sub>R &#x003b1;1-Usp14 binding, and consequently the gene expression knockdown of Usp14 in <italic>ax</italic><sup>J</sup> mice, is directly causal for increased GABA<sub>A</sub>R surface membrane expression, known to result in enlarged IPSC amplitudes <italic>in vivo</italic>.</p><fig id="pgen-1000631-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000631.g006</object-id><label>Figure 6</label><caption><title><italic>In vitro</italic> interference of GABA<sub>A</sub>R &#x003b1;1-Usp14 binding mimics <italic>ax</italic><sup>J</sup><italic>in vivo</italic> results.</title><p>(A,B) Quantitative biotinylation assay upon HEK293 cell expression of GABA<sub>A</sub>R &#x003b1;1-GFP, GABA<sub>A</sub>R &#x003b2;3 with either mRFP or mRFP-GABA<sub>A</sub>R &#x003b1;1(334&#x02013;346), respectively. GABA<sub>A</sub>R &#x003b1;1 cell surface expression is significantly increased through blockade of GABA<sub>A</sub>R &#x003b1;1&#x02013;Usp14 binding in the presence of the competitive peptide mRFP-GABA<sub>A</sub>R &#x003b1;1(334&#x02013;346). (C,D) Quantitative biotinylation assay upon HEK293 cell expression of GABA<sub>A</sub>R &#x003b1;1-GFP, GABA<sub>A</sub>R &#x003b2;3 with either mRFP or a catalytic Usp14 mutant, respectively. GABA<sub>A</sub>R &#x003b1;1 cell surface expression is significantly increased in the presence of inactive Usp14. Cadherin detection served as loading controls. (E) Model of GABA<sub>A</sub>R turnover and sorting of ubiquitinated receptors.</p></caption><graphic xlink:href="pgen.1000631.g006"/></fig><p>Since Usp14 represents a protease, its enzymatic activity should also be critical in this respect. To test this, we transfected HEK293 cells with constructs encoding GABA<sub>A</sub>R &#x003b1;1-GFP, GABA<sub>A</sub>R &#x003b2;3 and a catalytically inactive Usp14 mutant or with mRFP, respectively. Overexpression of the loss-of-function mutant, notably resulted in 3-fold enrichment of GABA<sub>A</sub>R &#x003b1;1-GFP surface expression (<xref ref-type="fig" rid="pgen-1000631-g006">Figure 6C and 6D</xref>), as compared to control experiments, indicating that a balanced turnover of &#x003b1;1-containing GABA<sub>A</sub>Rs indeed requires a catalytically intact Usp14 enzyme.</p><p>In summary, these and other data in this study suggest that the function of Usp14 is directly involved in GABA<sub>A</sub>R turnover. Regulation of synaptic strength requires the precise control of neurotransmitter receptor numbers at synaptic sites. Our <italic>in vivo</italic> and <italic>in vitro</italic> observations in this study indicate the novel concept that DUB-dependent pathways regulate neurotransmitter receptor density and might participate in synaptic plasticity mechanisms. Since <italic>ax</italic><sup>J</sup> mice represent mutants that are exclusively deficient for the proteasome-associated form of Usp14, with deubiquitinating enzymes playing an important role in the UPS, our data suggest a role of the proteasome in GABA<sub>A</sub>R turnover. It has been shown, that epidermal growth factor receptors (EGFRs), once activated, undergo ubiquitination and internalization from the plasma membrane <xref ref-type="bibr" rid="pgen.1000631-Alwan1">&#x0005b;43&#x0005d;</xref>. Prior to their sorting into multivesicular bodies (MVBs), EGFRs require deubiquitination, a process that depends on proteasomal activity, although EGFRs, such as most transmembrane proteins, undergo degradation at lysosomes. Recent data in yeast further confirm a proteasomal contribution in similar processes, by showing that the proteasome-associated deubiquitinating enzyme Doa4 removes ubiquitin from cargo proteins prior to their entry into internal vesicles of MVBs <xref ref-type="bibr" rid="pgen.1000631-Katzmann1">&#x0005b;14&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Losko1">&#x0005b;44&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Dupre1">&#x0005b;45&#x0005d;</xref>.</p><p>Usp14, as it binds to the proteasome and mediates deubiquitination, is therefore a candidate factor to serve in similar pathways in neurons (<xref ref-type="fig" rid="pgen-1000631-g006">Figure 6E</xref>). Consequently, Usp14 might represent the responsible DUB to trigger GABA<sub>A</sub>R transport from early endosomes into MVBs/lysosomes, although it might already interfere with GABA<sub>A</sub>Rs at the cell surface or right after internalization (<xref ref-type="fig" rid="pgen-1000631-g006">Figure 6E</xref>). Interruption of this function, either by loss of Usp14 (<italic>ax</italic><sup>J</sup> mice), or by interference with Usp14-GABA<sub>A</sub>Rs &#x003b1;1 binding (HEK293 cells), might either induce (i) backpropagation of disturbed endocytic pathways, leading to maintenance of the receptor at the cell surface or (ii) increased recycling of receptors back to the cell surface. Although an exact molecular mechanism remains to be elucidated, Usp14 represents a novel candidate to participate in the regulation of GABA<sub>A</sub>R turnover and synaptic plasticity at GABAergic synapses.</p><p>Since <italic>ax</italic><sup>J</sup> animals show further neuronal abnormalities, such as impaired synaptic transmission at neuromuscular junctions, their neurological phenotype might be due to a combination of deficits. However, we conclude that impaired GABA<sub>A</sub>R turnover in PCs due to the loss of Usp14 significantly contributes to the ataxic phenotype in <italic>ax</italic><sup>J</sup> mice. This view is supported by previous studies, which report that mouse mutants with altered GABA<sub>A</sub>R densities or reduced GABAergic terminals in the cerebellum, also develop severe motor impairments <xref ref-type="bibr" rid="pgen.1000631-GrusserCornehls1">&#x0005b;1&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Herrup1">&#x0005b;25&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Mullen1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Patil1">&#x0005b;46&#x0005d;</xref>. For instance the <italic>pcd</italic> mouse mutant, characterized by a complete loss of PCs, shows ataxia. PC degeneration in <italic>pcd</italic> mice results in a loss of inhibitory PC output and consequently a reduced inhibitory input to the vestibular nuclei, representing one of the direct PC target regions. In addition, altered Purkinje cell input leads to ataxia. Hence, mice deficient for the GABA transporter GAT1 develop severe ataxia due to disturbed GABA re-uptake. Consequently, this functional deficit leads to an increased GABA<sub>A</sub> receptor-mediated tonic conductance and prolonged IPSCs in both cerebellar granule and Purkinje cells <xref ref-type="bibr" rid="pgen.1000631-Chiu1">&#x0005b;30&#x0005d;</xref>. It is therefore a possible scenario that motor impairments are closely linked to the level of inhibition within cerebellar circuits. The observed increase in GABA<sub>A</sub>R surface expression and IPSC amplitudes in <italic>ax</italic><sup>J</sup> mice, as reported in this study, negatively affect PC functions and are likely to contribute to the ataxic symptoms. In parallel other yet unknown changes might be involved, too. Hence, in addition to GABAergic transmission, ubiquitin-mediated pathways might be putative targets for therapeutic treatment against certain forms of cerebellar ataxia.</p></sec></sec><sec sec-type="methods" id="s3"><title>Methods</title><sec id="s3a"><title>DNA constructs</title><p>The entire cDNA sequence of GABA<sub>A</sub>R &#x003b1;1 was subcloned as an <italic>EcoR</italic>I/<italic>Sal</italic>I fragment into the pEGFP-N vector (BD Biosciences). The cDNA of Usp14 was subcloned as a <italic>Bam</italic>HI fragment into the pFLAG-CMV-2 vector (Sigma). HA-tagged Ubiquitin was subcloned as an <italic>Eco</italic>RI/<italic>Xho</italic>I fragment into the pcDNA3f vector (Invitrogen). Single mutations (Usp14: C114A; GABA<sub>A</sub>R &#x003b1;1 loop: introduction of stop codons to generate deletion mutants and the competitive peptide, respectively) or group mutations (Usp14: H434A-D450A) were introduced using the site-directed mutagenesis kit (Stratagene).</p></sec><sec id="s3b"><title>Antibodies</title><p>Immunofluorescence: rabbit anti-GABA<sub>A</sub>R &#x003b1;1 (1&#x02236;250 Upstate); guinea pig anti-GABA<sub>A</sub>R &#x003b1;1 (1&#x02236;6000); rabbit anti-Usp14 <xref ref-type="bibr" rid="pgen.1000631-Borodovsky1">&#x0005b;10&#x0005d;</xref> rabbit anti-Usp14 (138-R/PB&#x0002b;2, SM Wilson-lab.); mouse anti-Calbindin (1&#x02236;100, Sigma); mouse anti-synaptic vesicle (SV2, 1&#x02236;100, Hybridoma bank, University of Iowa); Secondary antibodies: CY3-, CY2- or CY5-conjugated donkey-anti rat, mouse, guinea pig or rabbit (all 1&#x02236;500, Dianova).</p><p>Immunoprecipitation/Western blot analysis: rabbit anti-GABA<sub>A</sub>R &#x003b1;1 (1&#x02236;500 Upstate, 1&#x02236;1000 AbD serotec); guinea pig anti-GABA<sub>A</sub>R &#x003b1;1 (1&#x02236;6000 JM Fritschy-lab.); mouse-anti-Usp14 (IA4; 1&#x02236;1000, SM Wilson-lab.) mouse anti-pan Cadherin (1&#x02236;100, Abcam); mouse anti-N-Cadherin (1&#x02236;4000, Cell Signaling Technology); rabbit anti-actin (1&#x02236;2000, Sigma); mouse anti-HA (1&#x02236;1000, Sigma; 1&#x02236;1000, Santa Cruz Biotechnology); anti-GFP (1&#x02236;1000, Roche), mouse anti-rpt4 (1&#x02236;1000, Biomol) Secondary antibodies: HRP-conjugated goat-anti rabbit, guinea pig and mouse (all 1&#x02236;10.000, Dianova); HRP-conjugated protein A (1&#x02236;1000, KPL); biotinylated secondary antibodies (1&#x02236;1000, Vector laboratories), gold-labeled secondary antibodies.</p><sec id="s3b1"><title>Transfection and immunostaining</title><p>Primary cultures of hippocampal or cerebellar neurons were prepared from mice (P0-P1) and cells were transfected using a Ca<sup>2&#x0002b;</sup> phosphate coprecipitation protocol, as previously described (2.0&#x02013;2.5 &#x000b5;g DNA/coverslip and 3.5 cm dish) <xref ref-type="bibr" rid="pgen.1000631-Loebrich1">&#x0005b;47&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Maas1">&#x0005b;48&#x0005d;</xref>. Immuno-histochemistry: wt and ax<sup>J</sup> mice were anaesthetized and perfused with 2&#x02013;4&#x00025; paraformaldehyde (PFA). Brains were postfixed in 2&#x02013;4&#x00025; PFA for 1 h. For immunostaining floating vibratome sections (20 &#x000b5;m) were permeabilized (0,4&#x00025; Triton X-100). After 30 min incubation in blocking solution (4&#x00025; horse serum (HS), 0.2&#x00025; TritonX-100) primary antibodies were applied (2&#x00025; HS, 0.1&#x00025; TrotinX-100). Secondary antibody incubation was performed for 2 h in 1.5&#x00025; HS. Slices were analysed with an inverted Leica TCS-SP2 laser scanning confocal microscope (Leica). For double-labeling studies, a sequential scanning mode was used.</p><p>Immunocytochemistry: Primary neurons (DIV 12&#x02013;14) were fixed in 4&#x00025; PFA/4&#x00025; sucrose (12 min) and washed in PBS prior to permeabilization with 0.25&#x00025; Triton X-100 (4 min). Unspecific binding sites were blocked with 1&#x00025; BSA for 30 min and cells were incubated with primary antibodies for 1 h at room temperature (RT). Cells were washed three times in PBS and incubated with secondary antibodies. Microscopy analysis was carried out with an inverted Leica TCS-SP2 laser scanning confocal microscope (Leica). For double-labeling studies, a sequential scanning mode was used.</p></sec></sec><sec id="s3c"><title>Electron microscopy</title><p>Preembedding immunocytochemistry: mice were anaesthetized and perfused with 4&#x00025; PFA with 0.1&#x00025; glutaraldehyde in PBS. Sagittal vibratome sections of the cerebellum were cut (60 &#x000b5;m). After washing in PBS, sections were treated with 0.3&#x00025; H<sub>2</sub>O<sub>2</sub> and 1&#x00025; NaBH<sub>4</sub> in PBS for 30 min. After rinsing in PBS, sections were incubated with 10&#x00025; horse serum (HS) containing 0.2&#x00025; BSA for 15 min and subsequently incubated over night with primary antibodies in PBS, containing 1&#x00025; PS and 0.2&#x00025; BSA (carrier). Sections were washed in PBS, incubated with biotinylated secondary antibody and diluted in carrier for 90 min. After rinsing, sections were incubated with ABC (Vector Labs) and diluted to a 1&#x02236;100 concentration in PBS for 90 min. Afterwards they were washed in PBS and further incubated in diaminobenzidine (DAB)-H<sub>2</sub>0<sub>2</sub> solution (Sigma) for 10 min. Sections were then either mounted on glass coverslips (light microscopy) or postfixed with 1&#x00025; OsO<sub>4</sub>, dehydrated in an ascending series of ethanol and embedded in Epon (Roth). Ultrathin sections were examined with a Zeiss EM 902.</p><p>Immunocytochemistry of ultrathin frozen sections: mice were perfused and cerebellar sections of the cerebellum were cut (100&#x02013;200 &#x000b5;m), as described above. Small blocks of cerebellar tissue containing all layers were immersed in 12&#x00025; gelatin in PBS at 37&#x000b0;C for 15&#x02013;30 min. Blocks were transferred into vials containing 2.3 M sucrose in PBS and incubated over night. Thereafter they were frozen on specimen holders in liquid nitrogen. Ultrathin sections were prepared at a Reichard Ultracut microtome, equipped with a cryochamber and placed on copper grids (Sciences Services). Single and double immunogold labeling was performed according to Slot and Geuze using secondary 10 nm large protein A gold to label rabbit primary antibodies and 6 nm large gold (Dianova) to label guinea pig primary antibodies <xref ref-type="bibr" rid="pgen.1000631-Slot1">&#x0005b;49&#x0005d;</xref>.</p></sec><sec id="s3d"><title>Electrophysiology</title><p>Mice were anaesthetized and the cerebellar vermis prepared in ice-cold carboxygenated ACSF (NaCl 135 mM; KCl, 5 mM; CaCl<sub>2</sub> 2 mM; MgCl<sub>2</sub> 1 mM; glucose 10 mM; Na<sub>2</sub>HCO<sub>3</sub>, 30 mM; NaHPO<sub>4</sub>, 1.5 mM; pH 7.4 (bubbled with carbogen)). The tissue was cut into 200 &#x000b5;m sagittal sections (Microm HM 650V; Histoacryl glue, Braun), that were transferred to carboxygenated ACSF at 35&#x000b0;C for 20&#x02013;30 min before being kept at RT (22&#x02013;24&#x000b0;C), until further use.</p><p>Slices were placed in a recording chamber (RC26GLP, Warner Instr.) under an upright microscope (BX51WI, Olympus). Individual PCs were visually identified and recorded with borosilicate capillaries of approximately 5 MO resistance (Hilgenberg) using the whole-cell patch-clamp configuration. Spontaneous synaptic events were recorded under equimolare Cl<sup>&#x02212;</sup> concentrations at &#x02212;60 mV and the GABAergic input isolated using the AMPA-type glutamate antagonist CNQX; the remaining IPSCs could be blocked by 20 &#x000b5;M bicuculline (<xref ref-type="supplementary-material" rid="pgen.1000631.s002">Figure S2A</xref>). IPSC were recorded at 10 kHz for 60 s every 10 min. over approximately 1 h using the Patchmaster 2.05 software (HEKA). Data were analysed with the MiniAnalysis 6.02 program (Synaptosoft; converted with the supplied ABF Utility) using identical parameters for evaluating all IPSCs. Intracellular electrode: CsCl, 125 mM; MgCl<sub>2</sub>, 2 mM; EGTA 0.1 mM; TEA 5 mM; Na<sub>2</sub>-ATP, 4 mM; Na-GTP, 0.5 mM; HEPES, 10 mM; pH 7.3 (CsOH).</p></sec><sec id="s3e"><title>Coimmunoprecipitation/GST-pulldown assay</title><p>HEK293 cells were harvested in 1&#x00025; Triton X-100, 48 h after transfection. Antibodies were coupled to 30 &#x000b5;l of protein G beads (Dynal Biotech) in IP washing buffer (50 mM TrisHCl, 150 mM NaCl, 5 mM MgCl<sub>2</sub>, PH 7.1). Cell extracts were incubated with the beads over night, then washed and boiled in SDS sample buffer. For GST-pulldown experiments, HEK293 cells were harvested 48 h after transfection in 1 ml 1&#x00025; Triton X-100. <italic>E. coli</italic> BL21 lysates were obtained by sonification and centrifugation at 10,000&#x000d7;g for 30 min. Bacterial lysates were coupled to glutathione-sepharose beads (Amersham) for 3 h. HEK293 cell lysates were applied to the beads for 10&#x02013;12 h. Beads were washed and boiled prior to Western blot analysis. Proteins separated by SDS PAGE were transferred to PVDF or nitrocellulose membranes and unspecific binding sites were blocked using PBS containing 0.1&#x00025; Tween and 5&#x00025; skim milk powder. Primary and secondary antibody incubation was performed in blocking solution.</p></sec><sec id="s3f"><title>Ubiquitination analysis</title><p>HEK293T cells were transfected using GeneJuice Transfection Reagent (10 &#x000b5;g DNA/10 cm dish). 48&#x02013;72 h after transfection, cells were lysed in lysis buffer (50 mM HEPES, 150 mM NaCl, 10&#x00025; glycerol, 1 mM EGTA, 1 mM EDTA, 25 mM NaF, 10 &#x000b5;M ZnCl2 pH 7.5) supplemented with 10 mM NEM to inhibit deubiquitinating enzymes as well as protease and phosphatase inhibitors (10 &#x000b5;g/ml Aprotinin; 2 &#x000b5;g/ml Leupeptin; 1 mM PMSF; 1 mM Na-orthovanadate). Cell lysates were preincubated with 20&#x02013;25 &#x000b5;l Protein A/G PLUS Agarose (Santa Cruz Biotechnology) to remove unspecifically bound proteins. Immunoprecipitation using anti-GFP antibodies (1.0&#x02013;1.2 &#x000b5;g; Roche) was performed overnight at 4&#x000b0;C. Proteins bound to GFP-Antibodies were precipitated by adding 25 &#x000b5;l Protein A/G PLUS Agarose (Santa Cruz Biotechnology) followed by incubation for 45 min at 4&#x000b0;C. Precipitates were analysed by western blot analysis as described above considering the following differences. Unspecific binding sites were blocked using TBS (150 mM NaCl, 50 mM Tris, 0.1&#x00025; Na-Azide, 0.5&#x00025; v/v phenol red) containing 5&#x00025; BSA. Primary antibodies were diluted in TBS/5&#x00025; BSA.</p><sec id="s3f1"><title>Differential centrifugation</title><p>Total brain lysates from wt and <italic>ax</italic><sup>J</sup> mice were prepared and homogenized in 1 ml sucrose buffer (320 mM sucrose, 1 mM EGTA, 4 mM HEPES, 1 mM EDTA, pH 7.4, protease inhibitor cocktail (MiniComplete 1 tablet/10 ml Roche). After initial centrifugation at 1,000&#x000d7;g followed by centrifugation at 10,000&#x000d7;g for 10 min, each cell surface membrane-enriched P2 pellet was obtained. P3 pellets mainly contained small organelles and vesicles upon a 1 h centrifugation-step at 100,000&#x000d7;g. Upon an additional centrifugation step at 400,000&#x000d7;g for 1 h, protein complexes were enriched in the P4 pellet <xref ref-type="bibr" rid="pgen.1000631-Saito1">&#x0005b;50&#x0005d;</xref>.</p></sec></sec><sec id="s3g"><title>Surface biotinylation</title><p>48 h after transfection, HEK293 cells were incubated (20 min; 4&#x000b0;C) with HEPES containing 1 mM biotinamidohexanoic acid 3-sulfo-N-hydroxysuccinimid-ester sodium salt (Sigma). Remaining biotin reagent was quenched by adding 100 mM glycine (twice for 20 min at 4&#x000b0;C). Cells were washed with ice cold PBS and lysed in PBS containing 1&#x00025; Triton X-100 and protease inhibitor cocktail (MiniComplete 1 tablet/10 ml Roche). After a 30 min incubation step on ice, followed by a brief centrifugation-step at 1,000&#x000d7;g (5 min, 4&#x000b0;C), 30 &#x000b5;l of the supernatants were loaded on a gel to evaluate the amount of GABA<sub>A</sub>R &#x003b1;1-GFP. After quantification adjusted volumes of supernatants were added to 30 &#x000b5;l of prewashed magnetic Streptavidin MyOne beads (Dynal) to achieve equal amounts of GABA<sub>A</sub>R &#x003b1;1-GFP used for precipitation. Beads were incubated at 4&#x000b0;C for 3 h on a rotation wheel, washed 3 times, collected and boiled in SDS sample buffer.</p></sec><sec id="s3h"><title>Yeast two hybrid system</title><p>For protein-protein interaction analysis, the Matchmaker LexA yeast Two-Hybrid system (Clontech, Heidelberg, Germany) was used. Interactions of bait (pGilda) and prey (pJG4-5) fusion proteins were examined by activation of a LEU2 and a lacZ reporter gene <xref ref-type="bibr" rid="pgen.1000631-Loebrich1">&#x0005b;47&#x0005d;</xref>.</p></sec><sec id="s3i"><title><italic>In situ</italic> hybridisation</title><p>For detection of GABA<sub>A</sub>R &#x003b1;1 mRNAs, antisense oligonucleotides were synthesized encoding the large intracellular loop region between transmembrane domains M3 and M4 (aa 342-356) <xref ref-type="bibr" rid="pgen.1000631-Wisden2">&#x0005b;51&#x0005d;</xref>. In situ hybridization was performed as previously described <xref ref-type="bibr" rid="pgen.1000631-Wisden2">&#x0005b;51&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Fehr1">&#x0005b;52&#x0005d;</xref>.</p></sec></sec><sec sec-type="supplementary-material" id="s4"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pgen.1000631.s001"><label>Figure S1</label><caption><p>Immunohistochemical control staining of cerebellar slices derived from (A,C) wt and (B,D) GABA<sub>A</sub>R &#x003b1;1 knockout mice using GABA<sub>A</sub>R &#x003b1;1-specific antibodies (Upstate Biotechnology, New York). A significantly reduced signal in the granular and molecular layer of GABA<sub>A</sub>R &#x003b1;1-deficient cerebella is seen. (C,D) Magnifications of the Purkinje cell layer of (C) wt and (D) GABA<sub>A</sub>R &#x003b1;1 knockout mice. Scale bar: 100 &#x000b5;m. (D) Since GABA<sub>A</sub>R &#x003b1;1-deficient mutants do not carry a complete gene deletion, but express a remaining N-terminal protein fragment that is recognized by the antibody, cells represented by strong GABA<sub>A</sub>R &#x003b1;1 expression levels, such as Purkinje cells and granule cells, show a prominent cytoplasmic staining (white arrowheads) (Schneider Gasser et al. (2007) Eur J Neurosci 25: 3287&#x02013;3304). Scale bars in (A) and (B): 500 &#x000b5;m. (E,F) Immunocytochemical analysis of Usp14 (green) and (E) synaptic vesicle (SV) protein 2 (blue) or (F) GABA<sub>A</sub>R &#x003b1;1 (red) in cultured cerebellar neurons revealed partial colocalization of Usp14 with both proteins. Scale bar: 5 &#x000b5;m.</p><p>(5.27 MB TIF)</p></caption><media xlink:href="pgen.1000631.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000631.s002"><label>Figure S2</label><caption><p>Electrophysiological control analysis. (A) No spontaneous inhibitory postsynaptic currents were recorded in the presence of the GABA<sub>A</sub>R antagonist bicuculline in <italic>ax</italic><sup>J</sup> mice (dark line). A slight shift in baseline currents was attributable to the overlap of successive IPSCs. (B) Cumulative amplitude fractions averaged over six cells for <italic>ax</italic><sup>J</sup> and wt mice. Data of the individual cells are shown as dotted lines. (C) Kinetic parameters of rise-times (10&#x02013;90&#x00025;) and decay time-constants from 100 individual IPSCs, each. The sIPSCs represented by values below 1.7 ms were analysed separately (somatic origin). A tendency towards slower decay times is indicated through increasing sIPSCs amplitudes and is most apparent at amplitudes above 150 pA in <italic>ax</italic><sup>J</sup> animals, as compared to sIPSCs in wt animals that are in the range of 80 to 150 pA (p&#x0200a;&#x0003d;&#x0200a;0.005). Error bars represent SD values.</p><p>(0.32 MB TIF)</p></caption><media xlink:href="pgen.1000631.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000631.s003"><label>Figure S3</label><caption><p>Activity assay using a HA-tagged ubiquitin vinyl methyl ester (HAub-VME) probe, that covalently modifies active deubiquitinating enzymes with an HA tag <xref ref-type="bibr" rid="pgen.1000631-Borodovsky2">&#x0005b;41&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000631-Walters1">&#x0005b;42&#x0005d;</xref>. (A) Western blot analysis of protein extracts derived from <italic>ax</italic><sup>J</sup> and wt kidney, as well as from cultured HEK293 cells using HA-specific antibodies, revealed a signal in the height of Usp14 (upper signal) and UCH-37 (lower signal), the latter representing another deubiquitinating enzyme (Holzl et al. (2000) J Cell Biol 150: 119&#x02013;130). The Usp14 signal intensity (upper) is significantly reduced in <italic>ax</italic><sup>J</sup> kidney extracts, whereas the UCH-37 signal intensities (lower) remain equal, thereby supporting the specificity of the assay. (B) Western blot analysis of the same protein fractions as loaded in (A), using antibodies specific to Usp14 and a proteasomal marker protein Rpn4 (loading control). USP14 is endogenously expressed in HEK293 cells and in kidney tissue derived from wt mice. As expected, Usp14 is not detectable in kidney tissue derived from <italic>ax</italic><sup>J</sup> mutants.</p><p>(0.46 MB TIF)</p></caption><media xlink:href="pgen.1000631.s003.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000631.s004"><label>Figure S4</label><caption><p>Analysis of GABA<sub>A</sub>R &#x003b1;1 ubiquitination. (A) Immunoprecipitation of GFP-GABA<sub>A</sub>R &#x003b1;1 using anti-GFP antibodies upon HEK293T cell expression of GABA<sub>A</sub>R &#x003b1;1-GFP, GABA<sub>A</sub>R &#x003b2;3, HA-tagged ubiquitin and either Usp14 wt or catalytic mutant, respectively. GFP-GABA<sub>A</sub>R &#x003b1;1 expression was analysed using GABA<sub>A</sub>R &#x003b1;1-specific antibodies (lower panel). Upon membrane stripping and detection with anti-HA antibodies, ubiquitinated forms of GFP-GABA<sub>A</sub>R &#x003b1;1 are visible (upper panel, large bracket right). Note, the signal in the height of app. 75 kDa is due to a protein that unspecifically binds to agarose beads. (B) The marked region (asterisk, small bracket) detected in (A) (70&#x02013;100 kDa, middle and right lane) is enlarged. Note, more intense blurred signals in the presence of the Flag-tagged Usp14 catalytic mutant, indicative for ubiquitin-conjugated polypeptides, are visible (arrows, left lane), although the expression level of GABA<sub>A</sub>R &#x003b1;1 is lower (Figure S4C, lower panel, right lane). (C) Western blot analysis of total HEK293T cell lysates using anti-Flag (upper panel) or anti-GABA<sub>A</sub>R &#x003b1;1 (lower panel) antibodies.</p><p>(1.26 MB TIF)</p></caption><media xlink:href="pgen.1000631.s004.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank H. Plogh for the Usp-14 specific antibody, D. Magalei for the cDNA of GABA<sub>A</sub>R &#x003b2;3, and the members of the network grant DFG-FG885 for critical comments.</p></ack><ref-list><title>References</title><ref id="pgen.1000631-GrusserCornehls1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grusser-Cornehls</surname><given-names>U</given-names></name><name><surname>Baurle</surname><given-names>J</given-names></name></person-group><year>2001</year><article-title>Mutant mice as a model for cerebellar ataxia.</article-title><source>Prog Neurobiol</source><volume>63</volume><fpage>489</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">11164620</pub-id></mixed-citation></ref><ref id="pgen.1000631-Klockgether1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klockgether</surname><given-names>T</given-names></name><name><surname>Dichgans</surname><given-names>J</given-names></name></person-group><year>1997</year><article-title>The genetic basis of hereditary ataxia.</article-title><source>Prog Brain Res</source><volume>114</volume><fpage>569</fpage><lpage>576</lpage><pub-id pub-id-type="pmid">9193167</pub-id></mixed-citation></ref><ref id="pgen.1000631-Rosenberg1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>RN</given-names></name></person-group><year>1995</year><article-title>Autosomal dominant cerebellar phenotypes: the genotype has settled the issue.</article-title><source>Neurology</source><volume>45</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">7824096</pub-id></mixed-citation></ref><ref id="pgen.1000631-DAmato1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Amato</surname><given-names>CJ</given-names></name><name><surname>Hicks</surname><given-names>SP</given-names></name></person-group><year>1965</year><article-title>Neuropathologic alterations in the ataxia (paralytic) mouse.</article-title><source>Arch Pathol</source><volume>80</volume><fpage>604</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">5855800</pub-id></mixed-citation></ref><ref id="pgen.1000631-Wilson1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SM</given-names></name><name><surname>Bhattacharyya</surname><given-names>B</given-names></name><name><surname>Rachel</surname><given-names>RA</given-names></name><name><surname>Coppola</surname><given-names>V</given-names></name><name><surname>Tessarollo</surname><given-names>L</given-names></name><etal/></person-group><year>2002</year><article-title>Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease.</article-title><source>Nat Genet</source><volume>32</volume><fpage>420</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">12368914</pub-id></mixed-citation></ref><ref id="pgen.1000631-Ehlers1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehlers</surname><given-names>MD</given-names></name></person-group><year>2003</year><article-title>Ubiquitin and synaptic dysfunction: ataxic mice highlight new common themes in neurological disease.</article-title><source>Trends Neurosci</source><volume>26</volume><fpage>4</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12495853</pub-id></mixed-citation></ref><ref id="pgen.1000631-Yi1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>JJ</given-names></name><name><surname>Ehlers</surname><given-names>MD</given-names></name></person-group><year>2005</year><article-title>Ubiquitin and protein turnover in synapse function.</article-title><source>Neuron</source><volume>47</volume><fpage>629</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">16129392</pub-id></mixed-citation></ref><ref id="pgen.1000631-Chung1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>CH</given-names></name><name><surname>Baek</surname><given-names>SH</given-names></name></person-group><year>1999</year><article-title>Deubiquitinating enzymes: their diversity and emerging roles.</article-title><source>Biochem Biophys Res Commun</source><volume>266</volume><fpage>633</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">10603300</pub-id></mixed-citation></ref><ref id="pgen.1000631-Crimmins1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crimmins</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Wheeler</surname><given-names>C</given-names></name><name><surname>Huffman</surname><given-names>AK</given-names></name><name><surname>Chapman</surname><given-names>C</given-names></name><etal/></person-group><year>2006</year><article-title>Transgenic rescue of ataxia mice with neuronal-specific expression of ubiquitin-specific protease 14.</article-title><source>J Neurosci</source><volume>26</volume><fpage>11423</fpage><lpage>11431</lpage><pub-id pub-id-type="pmid">17079671</pub-id></mixed-citation></ref><ref id="pgen.1000631-Borodovsky1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borodovsky</surname><given-names>A</given-names></name><name><surname>Kessler</surname><given-names>BM</given-names></name><name><surname>Casagrande</surname><given-names>R</given-names></name><name><surname>Overkleeft</surname><given-names>HS</given-names></name><name><surname>Wilkinson</surname><given-names>KD</given-names></name><etal/></person-group><year>2001</year><article-title>A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14.</article-title><source>Embo J</source><volume>20</volume><fpage>5187</fpage><lpage>5196</lpage><pub-id pub-id-type="pmid">11566882</pub-id></mixed-citation></ref><ref id="pgen.1000631-Yin1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Krantz</surname><given-names>B</given-names></name><name><surname>Russell</surname><given-names>NS</given-names></name><name><surname>Deshpande</surname><given-names>S</given-names></name><name><surname>Wilkinson</surname><given-names>KD</given-names></name></person-group><year>2000</year><article-title>Nonhydrolyzable diubiquitin analogues are inhibitors of ubiquitin conjugation and deconjugation.</article-title><source>Biochemistry</source><volume>39</volume><fpage>10001</fpage><lpage>10010</lpage><pub-id pub-id-type="pmid">10933821</pub-id></mixed-citation></ref><ref id="pgen.1000631-DiAntonio1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiAntonio</surname><given-names>A</given-names></name><name><surname>Haghighi</surname><given-names>AP</given-names></name><name><surname>Portman</surname><given-names>SL</given-names></name><name><surname>Lee</surname><given-names>JD</given-names></name><name><surname>Amaranto</surname><given-names>AM</given-names></name><etal/></person-group><year>2001</year><article-title>Ubiquitination-dependent mechanisms regulate synaptic growth and function.</article-title><source>Nature</source><volume>412</volume><fpage>449</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">11473321</pub-id></mixed-citation></ref><ref id="pgen.1000631-Hicke1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hicke</surname><given-names>L</given-names></name><name><surname>Riezman</surname><given-names>H</given-names></name></person-group><year>1996</year><article-title>Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis.</article-title><source>Cell</source><volume>84</volume><fpage>277</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">8565073</pub-id></mixed-citation></ref><ref id="pgen.1000631-Katzmann1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katzmann</surname><given-names>DJ</given-names></name><name><surname>Babst</surname><given-names>M</given-names></name><name><surname>Emr</surname><given-names>SD</given-names></name></person-group><year>2001</year><article-title>Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I.</article-title><source>Cell</source><volume>106</volume><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">11511343</pub-id></mixed-citation></ref><ref id="pgen.1000631-Raiborg1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raiborg</surname><given-names>C</given-names></name><name><surname>Bache</surname><given-names>KG</given-names></name><name><surname>Gillooly</surname><given-names>DJ</given-names></name><name><surname>Madshus</surname><given-names>IH</given-names></name><name><surname>Stang</surname><given-names>E</given-names></name><etal/></person-group><year>2002</year><article-title>Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes.</article-title><source>Nat Cell Biol</source><volume>4</volume><fpage>394</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">11988743</pub-id></mixed-citation></ref><ref id="pgen.1000631-Buttner1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buttner</surname><given-names>C</given-names></name><name><surname>Sadtler</surname><given-names>S</given-names></name><name><surname>Leyendecker</surname><given-names>A</given-names></name><name><surname>Laube</surname><given-names>B</given-names></name><name><surname>Griffon</surname><given-names>N</given-names></name><etal/></person-group><year>2001</year><article-title>Ubiquitination precedes internalization and proteolytic cleavage of plasma membrane-bound glycine receptors.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>42978</fpage><lpage>42985</lpage><pub-id pub-id-type="pmid">11560918</pub-id></mixed-citation></ref><ref id="pgen.1000631-Saliba1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saliba</surname><given-names>RS</given-names></name><name><surname>Michels</surname><given-names>G</given-names></name><name><surname>Jacob</surname><given-names>TC</given-names></name><name><surname>Pangalos</surname><given-names>MN</given-names></name><name><surname>Moss</surname><given-names>SJ</given-names></name></person-group><year>2007</year><article-title>Activity-dependent ubiquitination of GABA(A) receptors regulates their accumulation at synaptic sites.</article-title><source>J Neurosci</source><volume>27</volume><fpage>13341</fpage><lpage>13351</lpage><pub-id pub-id-type="pmid">18045928</pub-id></mixed-citation></ref><ref id="pgen.1000631-Ogris1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogris</surname><given-names>W</given-names></name><name><surname>Lehner</surname><given-names>R</given-names></name><name><surname>Fuchs</surname><given-names>K</given-names></name><name><surname>Furtmuller</surname><given-names>B</given-names></name><name><surname>Hoger</surname><given-names>H</given-names></name><etal/></person-group><year>2006</year><article-title>Investigation of the abundance and subunit composition of GABAA receptor subtypes in the cerebellum of alpha1-subunit-deficient mice.</article-title><source>J Neurochem</source><volume>96</volume><fpage>136</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">16277610</pub-id></mixed-citation></ref><ref id="pgen.1000631-Fritschy1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritschy</surname><given-names>JM</given-names></name><name><surname>Panzanelli</surname><given-names>P</given-names></name><name><surname>Kralic</surname><given-names>JE</given-names></name><name><surname>Vogt</surname><given-names>KE</given-names></name><name><surname>Sassoe-Pognetto</surname><given-names>M</given-names></name></person-group><year>2006</year><article-title>Differential dependence of axo-dendritic and axo-somatic GABAergic synapses on GABAA receptors containing the alpha1 subunit in Purkinje cells.</article-title><source>J Neurosci</source><volume>26</volume><fpage>3245</fpage><lpage>3255</lpage><pub-id pub-id-type="pmid">16554475</pub-id></mixed-citation></ref><ref id="pgen.1000631-Wisden1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisden</surname><given-names>W</given-names></name><name><surname>Korpi</surname><given-names>ER</given-names></name><name><surname>Bahn</surname><given-names>S</given-names></name></person-group><year>1996</year><article-title>The cerebellum: a model system for studying GABAA receptor diversity.</article-title><source>Neuropharmacology</source><volume>35</volume><fpage>1139</fpage><lpage>1160</lpage><pub-id pub-id-type="pmid">9014130</pub-id></mixed-citation></ref><ref id="pgen.1000631-Wulff1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wulff</surname><given-names>P</given-names></name><name><surname>Goetz</surname><given-names>T</given-names></name><name><surname>Leppa</surname><given-names>E</given-names></name><name><surname>Linden</surname><given-names>AM</given-names></name><name><surname>Renzi</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors.</article-title><source>Nat Neurosci</source><volume>10</volume><fpage>923</fpage><lpage>929</lpage><pub-id pub-id-type="pmid">17572671</pub-id></mixed-citation></ref><ref id="pgen.1000631-Voogd1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voogd</surname><given-names>J</given-names></name><name><surname>Bigare</surname><given-names>F</given-names></name><name><surname>Gerrits</surname><given-names>NM</given-names></name><name><surname>Marani</surname><given-names>E</given-names></name></person-group><year>1981</year><article-title>Structure and fiber connections of the cerebellum.</article-title><source>Prog Clin Biol Res</source><volume>59A</volume><fpage>259</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">6170990</pub-id></mixed-citation></ref><ref id="pgen.1000631-Sotelo1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotelo</surname><given-names>C</given-names></name><name><surname>Alvarado-Mallart</surname><given-names>RM</given-names></name></person-group><year>1991</year><article-title>The reconstruction of cerebellar circuits.</article-title><source>Trends Neurosci</source><volume>14</volume><fpage>350</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">1721740</pub-id></mixed-citation></ref><ref id="pgen.1000631-Fletcher1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>CF</given-names></name><name><surname>Frankel</surname><given-names>WN</given-names></name></person-group><year>1999</year><article-title>Ataxic mouse mutants and molecular mechanisms of absence epilepsy.</article-title><source>Hum Mol Genet</source><volume>8</volume><fpage>1907</fpage><lpage>1912</lpage><pub-id pub-id-type="pmid">10469844</pub-id></mixed-citation></ref><ref id="pgen.1000631-Herrup1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrup</surname><given-names>K</given-names></name><name><surname>Wilczynski</surname><given-names>SL</given-names></name></person-group><year>1982</year><article-title>Cerebellar cell degeneration in the leaner mutant mouse.</article-title><source>Neuroscience</source><volume>7</volume><fpage>2185</fpage><lpage>2196</lpage><pub-id pub-id-type="pmid">7145091</pub-id></mixed-citation></ref><ref id="pgen.1000631-Lorenzon1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzon</surname><given-names>NM</given-names></name><name><surname>Lutz</surname><given-names>CM</given-names></name><name><surname>Frankel</surname><given-names>WN</given-names></name><name><surname>Beam</surname><given-names>KG</given-names></name></person-group><year>1998</year><article-title>Altered calcium channel currents in Purkinje cells of the neurological mutant mouse leaner.</article-title><source>J Neurosci</source><volume>18</volume><fpage>4482</fpage><lpage>4489</lpage><pub-id pub-id-type="pmid">9614225</pub-id></mixed-citation></ref><ref id="pgen.1000631-Mullen1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullen</surname><given-names>RJ</given-names></name><name><surname>Eicher</surname><given-names>EM</given-names></name><name><surname>Sidman</surname><given-names>RL</given-names></name></person-group><year>1976</year><article-title>Purkinje cell degeneration, a new neurological mutation in the mouse.</article-title><source>Proc Natl Acad Sci U S A</source><volume>73</volume><fpage>208</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">1061118</pub-id></mixed-citation></ref><ref id="pgen.1000631-Duenas1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duenas</surname><given-names>AM</given-names></name><name><surname>Goold</surname><given-names>R</given-names></name><name><surname>Giunti</surname><given-names>P</given-names></name></person-group><year>2006</year><article-title>Molecular pathogenesis of spinocerebellar ataxias.</article-title><source>Brain</source><volume>129</volume><fpage>1357</fpage><lpage>1370</lpage><pub-id pub-id-type="pmid">16613893</pub-id></mixed-citation></ref><ref id="pgen.1000631-Ohgoh1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohgoh</surname><given-names>M</given-names></name><name><surname>Yamazaki</surname><given-names>K</given-names></name></person-group><year>2003</year><article-title>Ataxia Jackson (ax(J)): a genetic model for apoptotic neuronal cell death.</article-title><source>Cerebellum</source><volume>2</volume><fpage>26</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">12882231</pub-id></mixed-citation></ref><ref id="pgen.1000631-Chiu1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>CS</given-names></name><name><surname>Brickley</surname><given-names>S</given-names></name><name><surname>Jensen</surname><given-names>K</given-names></name><name><surname>Southwell</surname><given-names>A</given-names></name><name><surname>McKinney</surname><given-names>S</given-names></name><etal/></person-group><year>2005</year><article-title>GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum.</article-title><source>J Neurosci</source><volume>25</volume><fpage>3234</fpage><lpage>3245</lpage><pub-id pub-id-type="pmid">15788781</pub-id></mixed-citation></ref><ref id="pgen.1000631-Hu1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Jeffrey</surname><given-names>PD</given-names></name><name><surname>Chenova</surname><given-names>TA</given-names></name><etal/></person-group><year>2005</year><article-title>Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14.</article-title><source>Embo J</source><volume>24</volume><fpage>3747</fpage><lpage>3756</lpage><pub-id pub-id-type="pmid">16211010</pub-id></mixed-citation></ref><ref id="pgen.1000631-Viltono1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viltono</surname><given-names>L</given-names></name><name><surname>Patrizi</surname><given-names>A</given-names></name><name><surname>Fritschy</surname><given-names>JM</given-names></name><name><surname>Sassoe-Pognetto</surname><given-names>M</given-names></name></person-group><year>2008</year><article-title>Synaptogenesis in the cerebellar cortex: differential regulation of gephyrin and GABAA receptors at somatic and dendritic synapses of Purkinje cells.</article-title><source>J Comp Neurol</source><volume>508</volume><fpage>579</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">18366064</pub-id></mixed-citation></ref><ref id="pgen.1000631-Nusser1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusser</surname><given-names>Z</given-names></name><name><surname>Roberts</surname><given-names>JD</given-names></name><name><surname>Baude</surname><given-names>A</given-names></name><name><surname>Richards</surname><given-names>JG</given-names></name><name><surname>Sieghart</surname><given-names>W</given-names></name><etal/></person-group><year>1995</year><article-title>Immunocytochemical localization of the alpha 1 and beta 2/3 subunits of the GABAA receptor in relation to specific GABAergic synapses in the dentate gyrus.</article-title><source>Eur J Neurosci</source><volume>7</volume><fpage>630</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">7620614</pub-id></mixed-citation></ref><ref id="pgen.1000631-Cooney1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooney</surname><given-names>JR</given-names></name><name><surname>Hurlburt</surname><given-names>JL</given-names></name><name><surname>Selig</surname><given-names>DK</given-names></name><name><surname>Harris</surname><given-names>KM</given-names></name><name><surname>Fiala</surname><given-names>JC</given-names></name></person-group><year>2002</year><article-title>Endosomal compartments serve multiple hippocampal dendritic spines from a widespread rather than a local store of recycling membrane.</article-title><source>J Neurosci</source><volume>22</volume><fpage>2215</fpage><lpage>2224</lpage><pub-id pub-id-type="pmid">11896161</pub-id></mixed-citation></ref><ref id="pgen.1000631-Mukherjee1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>RN</given-names></name><name><surname>Maxfield</surname><given-names>FR</given-names></name></person-group><year>1997</year><article-title>Endocytosis.</article-title><source>Physiol Rev</source><volume>77</volume><fpage>759</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">9234965</pub-id></mixed-citation></ref><ref id="pgen.1000631-Prekeris1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prekeris</surname><given-names>R</given-names></name><name><surname>Foletti</surname><given-names>DL</given-names></name><name><surname>Scheller</surname><given-names>RH</given-names></name></person-group><year>1999</year><article-title>Dynamics of tubulovesicular recycling endosomes in hippocampal neurons.</article-title><source>J Neurosci</source><volume>19</volume><fpage>10324</fpage><lpage>10337</lpage><pub-id pub-id-type="pmid">10575030</pub-id></mixed-citation></ref><ref id="pgen.1000631-Prekeris2"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prekeris</surname><given-names>R</given-names></name><name><surname>Klumperman</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>YA</given-names></name><name><surname>Scheller</surname><given-names>RH</given-names></name></person-group><year>1998</year><article-title>Syntaxin 13 mediates cycling of plasma membrane proteins via tubulovesicular recycling endosomes.</article-title><source>J Cell Biol</source><volume>143</volume><fpage>957</fpage><lpage>971</lpage><pub-id pub-id-type="pmid">9817754</pub-id></mixed-citation></ref><ref id="pgen.1000631-Park1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>M</given-names></name><name><surname>Penick</surname><given-names>EC</given-names></name><name><surname>Edwards</surname><given-names>JG</given-names></name><name><surname>Kauer</surname><given-names>JA</given-names></name><name><surname>Ehlers</surname><given-names>MD</given-names></name></person-group><year>2004</year><article-title>Recycling endosomes supply AMPA receptors for LTP.</article-title><source>Science</source><volume>305</volume><fpage>1972</fpage><lpage>1975</lpage><pub-id pub-id-type="pmid">15448273</pub-id></mixed-citation></ref><ref id="pgen.1000631-Mukhopadhyay1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukhopadhyay</surname><given-names>D</given-names></name><name><surname>Riezman</surname><given-names>H</given-names></name></person-group><year>2007</year><article-title>Proteasome-independent functions of ubiquitin in endocytosis and signaling.</article-title><source>Science</source><volume>315</volume><fpage>201</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">17218518</pub-id></mixed-citation></ref><ref id="pgen.1000631-Terrell1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terrell</surname><given-names>J</given-names></name><name><surname>Shih</surname><given-names>S</given-names></name><name><surname>Dunn</surname><given-names>R</given-names></name><name><surname>Hicke</surname><given-names>L</given-names></name></person-group><year>1998</year><article-title>A function for monoubiquitination in the internalization of a G protein-coupled receptor.</article-title><source>Mol Cell</source><volume>1</volume><fpage>193</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">9659916</pub-id></mixed-citation></ref><ref id="pgen.1000631-Borodovsky2"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borodovsky</surname><given-names>A</given-names></name><name><surname>Ovaa</surname><given-names>H</given-names></name><name><surname>Kolli</surname><given-names>N</given-names></name><name><surname>Gan-Erdene</surname><given-names>T</given-names></name><name><surname>Wilkinson</surname><given-names>KD</given-names></name><etal/></person-group><year>2002</year><article-title>Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family.</article-title><source>Chem Biol</source><volume>9</volume><fpage>1149</fpage><lpage>1159</lpage><pub-id pub-id-type="pmid">12401499</pub-id></mixed-citation></ref><ref id="pgen.1000631-Walters1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walters</surname><given-names>BJ</given-names></name><name><surname>Campbell</surname><given-names>SL</given-names></name><name><surname>Chen</surname><given-names>PC</given-names></name><name><surname>Taylor</surname><given-names>AP</given-names></name><name><surname>Schroeder</surname><given-names>DG</given-names></name><etal/></person-group><year>2008</year><article-title>Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity.</article-title><source>Mol Cell Neurosci</source><volume>39</volume><fpage>539</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">18771733</pub-id></mixed-citation></ref><ref id="pgen.1000631-Alwan1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alwan</surname><given-names>HA</given-names></name><name><surname>van Zoelen</surname><given-names>EJ</given-names></name><name><surname>van Leeuwen</surname><given-names>JE</given-names></name></person-group><year>2003</year><article-title>Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>35781</fpage><lpage>35790</lpage><pub-id pub-id-type="pmid">12829707</pub-id></mixed-citation></ref><ref id="pgen.1000631-Losko1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Losko</surname><given-names>S</given-names></name><name><surname>Kopp</surname><given-names>F</given-names></name><name><surname>Kranz</surname><given-names>A</given-names></name><name><surname>Kolling</surname><given-names>R</given-names></name></person-group><year>2001</year><article-title>Uptake of the ATP-binding cassette (ABC) transporter Ste6 into the yeast vacuole is blocked in the doa4 Mutant.</article-title><source>Mol Biol Cell</source><volume>12</volume><fpage>1047</fpage><lpage>1059</lpage><pub-id pub-id-type="pmid">11294906</pub-id></mixed-citation></ref><ref id="pgen.1000631-Dupre1"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupre</surname><given-names>S</given-names></name><name><surname>Haguenauer-Tsapis</surname><given-names>R</given-names></name></person-group><year>2001</year><article-title>Deubiquitination step in the endocytic pathway of yeast plasma membrane proteins: crucial role of Doa4p ubiquitin isopeptidase.</article-title><source>Mol Cell Biol</source><volume>21</volume><fpage>4482</fpage><lpage>4494</lpage><pub-id pub-id-type="pmid">11416128</pub-id></mixed-citation></ref><ref id="pgen.1000631-Patil1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>N</given-names></name><name><surname>Cox</surname><given-names>DR</given-names></name><name><surname>Bhat</surname><given-names>D</given-names></name><name><surname>Faham</surname><given-names>M</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name><etal/></person-group><year>1995</year><article-title>A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation.</article-title><source>Nat Genet</source><volume>11</volume><fpage>126</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">7550338</pub-id></mixed-citation></ref><ref id="pgen.1000631-Loebrich1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loebrich</surname><given-names>S</given-names></name><name><surname>Bahring</surname><given-names>R</given-names></name><name><surname>Katsuno</surname><given-names>T</given-names></name><name><surname>Tsukita</surname><given-names>S</given-names></name><name><surname>Kneussel</surname><given-names>M</given-names></name></person-group><year>2006</year><article-title>Activated radixin is essential for GABAA receptor alpha5 subunit anchoring at the actin cytoskeleton.</article-title><source>Embo J</source><volume>25</volume><fpage>987</fpage><lpage>999</lpage><pub-id pub-id-type="pmid">16467845</pub-id></mixed-citation></ref><ref id="pgen.1000631-Maas1"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maas</surname><given-names>C</given-names></name><name><surname>Tagnaouti</surname><given-names>N</given-names></name><name><surname>Loebrich</surname><given-names>S</given-names></name><name><surname>Behrend</surname><given-names>B</given-names></name><name><surname>Lappe-Siefke</surname><given-names>C</given-names></name><etal/></person-group><year>2006</year><article-title>Neuronal cotransport of glycine receptor and the scaffold protein gephyrin.</article-title><source>J Cell Biol</source><volume>172</volume><fpage>441</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">16449194</pub-id></mixed-citation></ref><ref id="pgen.1000631-Slot1"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slot</surname><given-names>JW</given-names></name><name><surname>Geuze</surname><given-names>HJ</given-names></name></person-group><year>2007</year><article-title>Cryosectioning and immunolabeling.</article-title><source>Nat Protoc</source><volume>2</volume><fpage>2480</fpage><lpage>2491</lpage><pub-id pub-id-type="pmid">17947990</pub-id></mixed-citation></ref><ref id="pgen.1000631-Saito1"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>N</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Noda</surname><given-names>Y</given-names></name><name><surname>Kinoshita</surname><given-names>Y</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><etal/></person-group><year>1997</year><article-title>KIFC2 is a novel neuron-specific C-terminal type kinesin superfamily motor for dendritic transport of multivesicular body-like organelles.</article-title><source>Neuron</source><volume>18</volume><fpage>425</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">9115736</pub-id></mixed-citation></ref><ref id="pgen.1000631-Wisden2"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisden</surname><given-names>W</given-names></name><name><surname>Laurie</surname><given-names>DJ</given-names></name><name><surname>Monyer</surname><given-names>H</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name></person-group><year>1992</year><article-title>The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon.</article-title><source>J Neurosci</source><volume>12</volume><fpage>1040</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">1312131</pub-id></mixed-citation></ref><ref id="pgen.1000631-Fehr1"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehr</surname><given-names>S</given-names></name><name><surname>Ivell</surname><given-names>R</given-names></name><name><surname>Koll</surname><given-names>R</given-names></name><name><surname>Schams</surname><given-names>D</given-names></name><name><surname>Fields</surname><given-names>M</given-names></name><etal/></person-group><year>1987</year><article-title>Expression of the oxytocin gene in the large cells of the bovine corpus luteum.</article-title><source>FEBS Lett</source><volume>210</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">3803580</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p>Supported by the University of Hamburg, Deutsche Forschungsgemeinschaft (DFG 556/1-3; DFG FG885-556/4-1), and the Chica and Heinz-Schaller Society to MK. Furthermore, by NIH Neuroscience Blueprint Core Grant NS57098 to the University of Alabama at Birmingham and NIH/NINDS grant NS047533 to SMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>